Enanta Pharmaceuticals — Capital Flow

$Open the interactive terminal to run `audit capital-flow` with custom options.→

Capital Flow Returns Earning Quality Debt Discipline Moat

Key Metrics

US.ENTA · YoY: 2026 9M vs 2025 9M

Metric	Value	YoY
FCF Conversion	100.6%	↓

Unlock Full Report

Sign up or upgrade to view the complete audit analysis.